Nigella sativa: reduces the risk of various maladies
- PMID: 20694927
- DOI: 10.1080/10408390902768797
Nigella sativa: reduces the risk of various maladies
Abstract
Coinage of terms like nutraceuticals, functional, and pharma foods has diverted the attention of human beings to where they are seeking more natural cures. Though pharmaceutical drugs have been beneficial for human health and have cured various diseases but they also impart some side effects. Numerous plants have been tested for their therapeutic potential; Nigella sativa, commonly known as black cumin, is one of them. It possesses a nutritional dense profile as its fixed oil (lipid fraction), is rich in unsaturated fatty acids while essential oil contains thymoquinone and carvacrol as antioxidants. N. sativa seeds also contain proteins, alkaloids (nigellicines and nigelledine), and saponins (alpha-hederin) in substantial amounts. Recent pharmacological investigations suggested its potential role, especially for the amelioration of oxidative stress through free radical scavenging activity, the induction of apoptosis to cure various cancer lines, the reduction of blood glucose, and the prevention of complications from diabetes. It regulates hematological and serological aspects and can be effective in dyslipidemia and respiratory disorders. Moreover, its immunopotentiating and immunomodulating role brings balance in the immune system. Evidence is available supporting the utilization of Nigella sativa and its bioactive components in a daily diet for health improvement. This review is intended to focus on the composition of Nigella sativa and to elaborate its possible therapeutic roles as a functional food to prevent an array of maladies.
Similar articles
-
Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review.J Ethnopharmacol. 2016 Aug 22;190:372-86. doi: 10.1016/j.jep.2016.06.061. Epub 2016 Jun 27. J Ethnopharmacol. 2016. PMID: 27364039 Review.
-
Overview of the preclinical pharmacological properties of Nigella sativa (black seeds): a complementary drug with historical and clinical significance.J Physiol Pharmacol. 2016 Dec;67(6):801-817. J Physiol Pharmacol. 2016. PMID: 28195061
-
Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review.Molecules. 2024 Oct 17;29(20):4914. doi: 10.3390/molecules29204914. Molecules. 2024. PMID: 39459282 Free PMC article. Review.
-
Comparative Studies on Polyphenolic Composition, Antioxidant and Diuretic Effects of Nigella sativa L. (Black Cumin) and Nigella damascena L. (Lady-in-a-Mist) Seeds.Molecules. 2015 May 26;20(6):9560-74. doi: 10.3390/molecules20069560. Molecules. 2015. PMID: 26016547 Free PMC article.
-
Designing novel industrial and functional foods using the bioactive compounds from Nigella sativa L. (black cumin): Biochemical and biological prospects toward health implications.J Food Sci. 2024 Apr;89(4):1865-1893. doi: 10.1111/1750-3841.16981. Epub 2024 Feb 26. J Food Sci. 2024. PMID: 38407314 Review.
Cited by
-
Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19.Front Plant Sci. 2021 Feb 16;11:601335. doi: 10.3389/fpls.2020.601335. eCollection 2020. Front Plant Sci. 2021. PMID: 33664752 Free PMC article. Review.
-
Studying the Anticancer Effects of Thymoquinone on Breast Cancer Cells through Natural Killer Cell Activity.Biomed Res Int. 2022 Sep 20;2022:9218640. doi: 10.1155/2022/9218640. eCollection 2022. Biomed Res Int. 2022. PMID: 36199754 Free PMC article.
-
Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review.Front Nutr. 2023 Sep 25;10:1126272. doi: 10.3389/fnut.2023.1126272. eCollection 2023. Front Nutr. 2023. PMID: 37818339 Free PMC article. Review.
-
Nigella sativa and health outcomes: An overview of systematic reviews and meta-analyses.Front Nutr. 2023 Mar 28;10:1107750. doi: 10.3389/fnut.2023.1107750. eCollection 2023. Front Nutr. 2023. PMID: 37057067 Free PMC article.
-
Potential Antidepressant Constituents of Nigella sativa Seeds.Pharmacogn Mag. 2016 Jan;12(Suppl 1):S27-31. doi: 10.4103/0973-1296.176118. Pharmacogn Mag. 2016. PMID: 27041854 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources